SCHEMBL30079196

SCHEMBL30079196

Cn1cc2c(n1)NC(=O)N(C1CCN(C(=O)OC(C)(C)C)C1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 3/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
PIK3CD O00329 1/20 0.41
DDB1 Q16531 3/20 0.40
CRBN Q96SW2 3/20 0.40
PRKCG P05129 1/20 0.39
PRKCB P05771 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCH P24723 1/20 0.39
PRKCE Q02156 1/20 0.39
PRKCD Q05655 1/20 0.39
SRC P12931 3/20 0.39
GPR119 Q8TDV5 2/20 0.39
EGFR P00533 1/20 0.39
CTSD P07339 1/20 0.38
CTSE P14091 1/20 0.38
BACE1 P56817 1/20 0.38
HCAR1 Q9BXC0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079439 0.94 DDB1 (0.43) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30079239 0.90 HCAR1 (0.46) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30079289 0.77 DDB1 (0.43) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL2209530 0.76 IDH1 (0.52) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL1813251 0.71 MAPT (0.49) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL2604336 0.71 CALCRL (0.58)
SCHEMBL18124095 0.70 KDM4E (0.48) USP30KDM4EMAPTTHRBGPR119
SCHEMBL2548432 0.70 KDM4E (0.48) USP30KDM4EMAPTTHRBGPR119
SCHEMBL3963958 0.70 KDM4E (0.44) USP30KDM4EMAPTTHRBDDB1
SCHEMBL24895522 0.69 MAPT (0.48) KDM4EMAPTTHRBDDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed